An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system

References

• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Gupta E, Barends DM, Yamashita E, Lentz KA, Harmsze AM, Shah VP et al. (2006). Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. Eur J Pharm Sci, 29:315–324.
   PubMed Web of Science ®Google Scholar
• Lennernäs H, Abrahamsson B. (2005). The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J Pharm Pharmacol, 57:273–285.
   PubMed Web of Science ®Google Scholar
• Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res, 15:698–705.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP et al. (2002). Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res, 19:921–925.
   PubMed Web of Science ®Google Scholar
• Lennernäs H. (2007). Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev, 59:1103–1120.
   PubMed Web of Science ®Google Scholar
• Bajka BH, Gillespie CM, Steeb CB, Read LC, Howarth GS. (2003). Applicability of the Ussing chamber technique to permeability determinations in functionally distinct regions of the gastrointestinal tract in the rat. Scand J Gastroenterol, 38:732–741.
   PubMed Web of Science ®Google Scholar
• Gotoh Y, Kamada N, Momose D. (2005). The advantages of the Ussing chamber in drug absorption studies. J Biomol Screen, 10:517–523.
   PubMed Web of Science ®Google Scholar
• Watanabe E, Takahashi M, Hayashi M. (2004). A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. Eur J Pharm Biopharm, 58:659–665.
   PubMed Web of Science ®Google Scholar
• Corti G, Maestrelli F, Cirri M, Zerrouk N, Mura P. (2006). Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability. Eur J Pharm Sci, 27:354–362.
   PubMed Web of Science ®Google Scholar
• Fagerholm U, Johansson M, Lennernäs H. (1996). Comparison between permeability coefficients in rat and human jejunum. Pharm Res, 13:1336–1342.
   PubMed Web of Science ®Google Scholar
• Lennernäs H, Nylander S, Ungell AL. (1997). Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans. Pharm Res, 14:667–671.
   PubMed Web of Science ®Google Scholar
• Obata K, Sugano K, Machida M, Aso Y. (2004). Biopharmaceutics classification by high throughput solubility assay and PAMPA. Drug Dev Ind Pharm, 30:181–185.
   PubMed Web of Science ®Google Scholar
• Lee HT, Seo EK, Chung SJ, Shim CK. (2005). Prokinetic activity of an aqueous extract from dried immature fruit of Poncirus trifoliata (L.) Raf. J Ethnopharmacol, 102:131–136.
   PubMed Web of Science ®Google Scholar
• Nikolai LN, McClure EL, Macleod SL, Wong CS. (2006). Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A, 1131:103–109.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Barzegar-Jalali M, Tajerzadeh H, Azarmi Y, Valizadeh H. (2005). Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J Pharm Biomed Anal, 39:624–630.
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Zakeri-Milani P, Islambulchilar Z, Tajerzadeh H. (2006). A simple and rapid high-performance liquid chromatography method for determining furosemide, hydrochlorothiazide, and phenol red: applicability to intestinal permeability studies. J AOAC Int, 89:88–93.
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Vali AM, Rezagholi N. (2002). LC determination of piroxicam in human plasma. J Pharm Biomed Anal, 28:1201–1204.
   PubMed Web of Science ®Google Scholar
• Hwang SM, Kim DD, Chung SJ, Shim CK. (2008). Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis. J Control Release, 129:100–106.
   PubMed Web of Science ®Google Scholar
• Piecyk M, Śrama A, Bzducha A, Obiedziński M. (2007). Application of HPLC and GC/MS to quantification of phenylalanine in chosen kinds of food for particular nutritional uses. Acta Sci Pol Technol Aliment, 6, 5–18.
   Google Scholar
• Srdjenovic B, Djordjevic-Milic V, Grujic N, Injac R, Lepojevic Z. (2008). Simultaneous HPLC determination of caffeine, theobromine, and theophylline in food, drinks, and herbal products. J Chromatogr Sci, 46:144–149.
   PubMed Web of Science ®Google Scholar
• Venkatesh G, Ramanathan S, Mansor SM, Nair NK, Sattar MA, Croft SL et al. (2007). Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies. J Pharm Biomed Anal, 43:1546–1551.
   PubMed Web of Science ®Google Scholar
• Karakus S, Küçükgüzel I, Küçükgüzel SG. (2008). Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. J Pharm Biomed Anal, 46:295–302.
   PubMed Web of Science ®Google Scholar
• Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DA. (1983). Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet, 2:1452–1454.
   PubMed Web of Science ®Google Scholar
• Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX. (2006). Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem, 41:605–610.
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. (2005). Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci, 94:1694–1704.
   PubMed Web of Science ®Google Scholar
• Volpe DA. (2004). Permeability classification of representative fluoroquinolones by a cell culture method. AAPS PharmSci, 6:e13.
   PubMedGoogle Scholar
• Plumb JA, Burston D, Baker TG, Gardner ML. (1987). A comparison of the structural integrity of several commonly used preparations of rat small intestine in vitro. Clin Sci (Lond), 73, 53–59.
   PubMed Web of Science ®Google Scholar
• Adson A, Raub TJ, Burton PS, Barsuhn CL, Hilgers AR, Audus KL et al. (1994). Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J Pharm Sci, 83:1529–1536.
   PubMed Web of Science ®Google Scholar
• Saitoh R, Sugano K, Takata N, Tachibana T, Higashida A, Nabuchi Y et al. (2004). Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans. Pharm Res, 21:749–755.
   PubMed Web of Science ®Google Scholar
• Federal Drug and Food Administration. (2002). Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Rockville, MD: FDA Guidance for Industry.
   Google Scholar
• Benet LZ, Broccatelli F, Oprea TI. (2011). BDDCS applied to over 900 drugs. AAPS J, 13:519–547.
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS et al. (2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm, 1:85–96.
   PubMed Web of Science ®Google Scholar
• Hiraoka H, Kimura N, Furukawa Y, Ogawara K, Kimura T, Higaki K. (2005). Up-regulation of P-glycoprotein expression in small intestine under chronic serotonin-depleted conditions in rats. J Pharmacol Exp Ther, 312:248–255.
   PubMed Web of Science ®Google Scholar
• Dahan A, Miller JM, Amidon GL. (2009). Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs. AAPS J, 11:740–746.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Islambulchilar Z. . (2009). The utility of rat jejunal permeability for biopharmaceutics classification system. Drug Dev Ind Pharm, 35:1496–1502.
   PubMed Web of Science ®Google Scholar
• Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. (2006). A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm, 3:631–643.
   PubMed Web of Science ®Google Scholar
• Grube S, Langguth P, Junginger HE, Kopp S, Midha KK, Shah VP et al. (2009). Biowaiver monographs for immediate release solid oral dosage forms: quinidine sulfate. J Pharm Sci, 98:2238–2251.
   Google Scholar
• Vogelpoel H, Welink J, Amidon GL, Junginger HE, Midha KK, Möller H et al. (2004). Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci, 93:1945–1956.
   PubMed Web of Science ®Google Scholar
• Kortejärvi H, Yliperttula M, Dressman JB, Junginger HE, Midha KK, Shah VP et al. (2005). Biowaiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride. J Pharm Sci, 94:1617–1625.
   PubMed Web of Science ®Google Scholar
• Sakore S, Choudhari S, Chakraborty B. (2010). Biowaiver monograph for immediate release solid oral dosage forms: ofloxacin. Int J Pharm Pharmaceu Sci, 2, 156–161.
   Google Scholar
• Granero GE, Longhi MR, Mora MJ, Junginger HE, Midha KK, Shah VP et al. (2010). Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J Pharm Sci, 99:2544–2556.
   PubMed Web of Science ®Google Scholar